Study Confirms Delta 8 THC's Safety and Benefits, Says 3CHI

INDIANAPOLIS, May 2, 2024 -- 3CHI has successfully completed a comprehensive safety and tolerability study of its Platinum Delta 8 THC oil, conducted in partnership with Hera Biolabs. This significant research confirms the safety of Delta 8 THC and highlights 3CHI's ongoing dedication to scientific advancements in the cannabinoid field. This study marks the first of several planned to validate and prove the safety and efficacy of 3CHI's products.

In this rigorous assessment, Sprague Dawley rats received various doses of 3CHI's 99% pure Platinum Delta 8 THC oil. The doses were calibrated to be equivalent to those a 70 kg human might receive, with quantities ranging from 10 mg to 500 mg. Throughout the study duration, the rats did not exhibit any significant adverse effects, thereby affirming the product's safety at all administered levels. Additionally, the study noted promising beneficial effects, which will be further investigated in upcoming clinical trials.

Justin Journay, CEO of 3CHI, commented on the study's findings, stating, "This research strengthens the safety profile of our Delta 8 THC and demonstrates that much of the criticism against Delta 8 THC products and the broader hemp industry lacks scientific backing. These critiques are often driven by competitors with profit-driven motives, many of whom are now ironically selling hemp products themselves."

Journay further pointed out, "The marijuana industry and their associated testing laboratories are significant sources of the misinformation prevalent in the hemp sector. They lack the expertise to keep pace with the rapid scientific developments within the hemp industry and resort to fearmongering and false prohibitionist tactics to protect their declining market share."

The study provides robust evidence for the safety of 3CHI's Platinum Delta 8 THC oil, reinforcing its safe usage, even beyond recommended doses. 3CHI continues to lead the industry by setting high standards for safety, transparency, and scientific integrity. Their proactive research approach and unwavering commitment to quality distinguish them in the rapidly evolving cannabis market.

This study not only assures consumers of the safety and potential benefits of Delta 8 THC but also positions 3CHI at the forefront of cannabinoid research and product development. The company's dedication to rigorous scientific validation and quality assurance is evident in their continuous efforts to bring safe and effective products to the market.

3CHI's mission is to maintain its pioneering role in the cannabinoid industry by prioritizing consumer safety and product transparency. Their ongoing research and development efforts are testament to their commitment to pushing the boundaries of cannabinoid science and providing high-quality, reliable products.

In conclusion, the successful completion of this safety study underscores 3CHI's leadership in the cannabinoid sector and their dedication to scientific excellence. As they continue to explore and validate the benefits of Delta 8 THC, 3CHI remains committed to upholding the highest standards of safety and integrity in their products.